2025

Peer-reviewed Publications

  1. Verma S, Leiter LA, Teoh H, Mancini GBJ, Quan A, Elituv R, Verma M, Misner E, Szarek M, Thorpe KE, Saha T, Whitlock RP, Yanagawa B, Merkely B, Jüni P, Koren MJ, Nicholls SJ, Bhatt DL, Mazer CD. Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery (NEWTON-CABG CardioLink-5): an international, randomised, double-blind, placebo-controlled trial. Lancet 2025 Sep 20;406(10509):1223-1234.
  2. Park B, Dennis F, He AZ, Krishnaraj A, Bakbak E, Dennis CJ, Pan Y, Misner E, Thayanithy V, Lambotharan B, Lambotharan V, Lambotharan A, Mazer CD, Quan A, Teoh H, Hess DA, Verma S. Semaglutide promotes bone marrow-derived progenitor cell flux toward an anti-inflammatory and pro-regenerative profile in high-risk patients: the SEMA-VR CardioLink-15 trial. Eur Heart J. 2025. https://doi.org/10.1093/eurheartj/ehaf690
  3. Moroney M, Casey JH, Teoh H, Krishnaraj A, Pan Y, Quan A, Patel SK, Dennis F, He AZ, Park B, Verma R, Misner E, Seguchi R, Hassan SMA, Dennis CJ, Meglis G, Pandey A, Butler J, Mazer CD, Byrne RA, Koschinsky ML, Hess DA, Verma S. Vascular regenerative deficiencies in people with elevated lipoprotein(a). The Lp(a)-VRCE CardioLink-16 translational study. Cardiovasc Res. 2025. Cardiovasc Res. 2025 Nov 22;121(14):2127-2130.
  4. Rumman R, Verma S, Chan V, Fottinger A, Quan A, Hibino M, de Varennes B, Daniel JP Burns, Chu MWA, Teoh H, Latter DA, Bisleri G, Leong-Poi, Mazer CD, Connelly KA. Comparison of myocardial mechanics post mitral valve repair with leaflet preservation vs. leaflet resection: Sub-analysis of the randomized CAMRA CardioLink-2 trial. J Thorac Cardiovasc Surg. (accepted)
  5. Mazer CD, Moody AR, Teoh H, Quan A, Elituv R, Vivekanandan T, Li P, Thorpe KE, Lafreniere-Roula M, Verma R, Moroney M, Casey JH, Singh N, Bharatha A, Mahmoud R, Manorajah R, Jayarajah A, Kapadia AN, Dueck AD, Al-Omran M, Bhatt DL, Leiter LA, Verma S.  SLICE-CEA CardioLink-8: A Randomized Trial of Evolocumab on Carotid Artery Atherosclerotic Plaque Characteristics in Asymptomatic High-Risk Carotid Stenosis. Circulation. 2025 Jan 28;151(4):351-355.
  6. Morales JF, Ricci MJ, Verma S, Dennis F, Chin K, Dhingra NK, Hassan SMA, de Vasconcelos Papa F, Derry KL, Quan A, Teoh H, Mazer CD, Alli A. How I do it ─ Superficial parasternal intercostal plane catheter insertion. JTCVS Tech. 2025 Jan 8;30:107-110.

Conference Abstracts

  1. Leiter LA, Verma S, Teoh H, Mancini GBJ, Szarek M, Quan A, Elituv R, Verma M, Misner E, Thorpe KE, Saha T, Whitlock RP, Yanagawa B, Merkely B, Jüni P, Koren MJ, Nicholls SJ, Bhatt DL, Mazer CD. Evolocumab and Saphenous Vein Graft Patency Following Coronary Artery Bypass Graft (CABG) Surgery in People with and without Diabetes: A Pre-Specified Analysis of the Randomized Placebo Controlled NEWTON-CABG CardioLink-5 Trial. Late Breaker at the American Heart Association, 7th-10th November, 2025, New Orleans, LA, USA.
  2. Verma S, Leiter LA, Teoh H, Mancini GBJ, Quan A, Szarek M, Mazer CD.  Randomized trial of intensive low-density lipoprotein cholesterol reduction with the proprotein convertase subtilisin/kexin type 9 inhibitor evolocumab on saphenous vein graft patency in South Asian patients following coronary artery bypass graft: A prespecified analysis of NEWTON-CABG CardioLink-5. Late Breaker at the EACTS Annual Meeting, 8th-11th October 2025, Copenhagen, Denmark.
  3. Casey JH, Moroney M, Krishnaraj A, Pan Y, Dennis F, He AZ,Park B, Verma R, Teoh H, Quan A, Hussain MA, Roche-Nagle G, Curley G, Hess DA, Verma S. Vascular regenerative cell exhaustion in adults with peripheral artery disease. 52nd Annual Meeting of the New England Society for Vascular Surgery, September 26-28, 2025, Providence, RI, USA.
  4. Moroney M, Casey JH, Krishnaraj A, Pan Y, Dennis F, He A, Verma R, Teoh H, Quan A, Pandey A, Butler J, Mazer CD, Byrne RA, Hess DA, Verma S. Vascular Regenerative Cell Content in People With Elevated Lipoprotein(a): Primary Results of The Lp(a)-VRCE Study. ESC Congress 2025, August 29-September 1, 2025, Madrid, Spain. Eur Heart J. 2025; 46 (Supplement_1): ehaf784.4619.
  5. Park B, Dennis F, He AZ, Quan A, Misner E, Thayanithy V, Bakbak E, Krishnaraj A, Lambotharan B, Lambotharan V, Lambotharan A, Teoh H, Mazer CD, Hess DA, Verma S. Primary Results of the Semaglutide and Vascular Regeneration (SEMA-VR) Translational Clinical Trial. ESC Congress 2025, August 29-September 1, 2025, Madrid, Spain.
  6. Verma S, Leiter LA, Teoh H, Mancini GBJ, Quan A, Elituv R, Verma M, Misner E, Szarek M, Thorpe KE, Saha T, Jüni P, Koren MJ, Nicholls SJ, Bhatt DL, Mazer CD. Primary results of NEWTON-CABG CardioLink-5: A randomized controlled trial of evolocumab and saphenous vein graft patency following coronary artery bypass graft surgery. Late Breaker at the ESC Congress 2025, 29th August-1st September 2025, Madrid, Spain.
  7. Hoxha T, Fottinger A, Rumman R, Hibino M, Seguchi R,† Hassan SMA, Chan V, Quan A, Chu MWA, Teoh H, Mazer CD, Connelly KA, Verma S. Association of intraoperative myocardial mechanics post mitral valve repair with strain at 1-year follow up: A sub-analysis of the CAMRA CardioLink-2 trial. Presented at the Annual Meeting of the American Association for Thoracic Surgeons, 2nd-5th May 2025, Seattle, Washington, USA.
  8. Hibino M, Mazer CD, Peterson MD, Quan A, Teoh H, Smith EE, Verma S. Serum sodium concentration and brain ischemic lesions in MRI: A sub-analysis of the ACE CardioLink-3 trial. Annual Scientific Session of the American College of Cardiology, March 29-31, 2025.Chicago, Illinois, USA. J Am Coll Cardiol. 2025;85 (12 Suppl):2403-2403.
© 2024 CardioLink Canada. All rights reserved